Free Trial

PowerUp Acquisition (PWUP) Competitors

PowerUp Acquisition logo
$0.22 -0.02 (-6.45%)
As of 05/21/2025

PWUP vs. CPHI, PMCB, ALBT, CTXR, LIPO, OMGA, CHRO, AIM, TRAW, and IMNN

Should you be buying PowerUp Acquisition stock or one of its competitors? The main competitors of PowerUp Acquisition include China Pharma (CPHI), PharmaCyte Biotech (PMCB), Avalon GloboCare (ALBT), Citius Pharmaceuticals (CTXR), Lipella Pharmaceuticals (LIPO), Omega Therapeutics (OMGA), Chromocell Therapeutics (CHRO), AIM ImmunoTech (AIM), Traws Pharma (TRAW), and Imunon (IMNN). These companies are all part of the "pharmaceutical products" industry.

PowerUp Acquisition vs.

China Pharma (NYSE:CPHI) and PowerUp Acquisition (NASDAQ:PWUP) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, community ranking, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.

China Pharma has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, PowerUp Acquisition has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500.

In the previous week, China Pharma had 2 more articles in the media than PowerUp Acquisition. MarketBeat recorded 2 mentions for China Pharma and 0 mentions for PowerUp Acquisition. PowerUp Acquisition's average media sentiment score of 0.00 beat China Pharma's score of -0.07 indicating that PowerUp Acquisition is being referred to more favorably in the news media.

Company Overall Sentiment
China Pharma Neutral
PowerUp Acquisition Neutral

PowerUp Acquisition has a net margin of 0.00% compared to China Pharma's net margin of -85.56%. PowerUp Acquisition's return on equity of 0.00% beat China Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
China Pharma-85.56% -63.93% -31.42%
PowerUp Acquisition N/A N/A N/A

PowerUp Acquisition has lower revenue, but higher earnings than China Pharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
China Pharma$4.53M1.63-$3.08MN/AN/A
PowerUp AcquisitionN/AN/AN/AN/AN/A

China Pharma and PowerUp Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
China PharmaOutperform Votes
No Votes
Underperform Votes
94
100.00%
PowerUp AcquisitionN/AN/A

19.2% of PowerUp Acquisition shares are owned by institutional investors. 17.3% of China Pharma shares are owned by insiders. Comparatively, 48.0% of PowerUp Acquisition shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

PowerUp Acquisition beats China Pharma on 6 of the 9 factors compared between the two stocks.

Get PowerUp Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for PWUP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PWUP vs. The Competition

MetricPowerUp AcquisitionHolding Offices IndustryManufacturing SectorNASDAQ Exchange
Market Cap$1.75M$478.96M$2.05B$8.42B
Dividend YieldN/A7.55%2.63%4.11%
P/E RatioN/A2.5322.6819.72
Price / SalesN/A74.2763.18121.26
Price / CashN/A69.0151.7234.62
Price / BookN/A6.862.074.51
Net IncomeN/A$35.22M-$292.00M$248.32M
7 Day Performance-30.87%0.98%0.03%0.60%
1 Month Performance-60.42%4.18%9.80%13.18%
1 Year Performance-98.10%29.14%12.84%7.39%

PowerUp Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PWUP
PowerUp Acquisition
N/A$0.22
-6.5%
N/A-97.9%$1.75MN/A0.00N/AHigh Trading Volume
CPHI
China Pharma
N/A$2.35
+8.8%
N/A-92.8%$7.67M$4.53M0.00250News Coverage
Analyst Upgrade
Gap Down
PMCB
PharmaCyte Biotech
1.1797 of 5 stars
$1.09
+5.7%
N/A-50.2%$7.34MN/A2.024
ALBT
Avalon GloboCare
0.5554 of 5 stars
$3.87
-1.7%
N/A-11.0%$7.33M$1.33M-0.195Upcoming Earnings
CTXR
Citius Pharmaceuticals
2.542 of 5 stars
$0.74
-3.3%
$54.50
+7,220.3%
-96.3%$7.32MN/A0.0020Gap Up
LIPO
Lipella Pharmaceuticals
0.956 of 5 stars
$2.85
+10.5%
N/A-49.7%$6.93M$536,357.00-0.644Gap Down
OMGA
Omega Therapeutics
2.3103 of 5 stars
$0.13
-21.8%
$9.20
+7,260.0%
-94.3%$6.92M$8.10M-0.09120News Coverage
Gap Up
CHRO
Chromocell Therapeutics
N/A$1.01
-4.3%
N/A-46.8%$6.63MN/A-0.814
AIM
AIM ImmunoTech
1.4432 of 5 stars
$0.09
-22.3%
$2.75
+2,908.8%
-77.7%$6.61M$170,000.00-0.1920Gap Down
High Trading Volume
TRAW
Traws Pharma
1.0044 of 5 stars
$1.24
-7.8%
N/AN/A$6.51M$226,000.00-0.0117Earnings Report
Gap Up
IMNN
Imunon
1.5886 of 5 stars
$0.44
-5.6%
$15.50
+3,391.0%
-72.3%$6.48M$500,000.00-0.2330News Coverage
Analyst Forecast
Gap Up

Related Companies and Tools


This page (NASDAQ:PWUP) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners